Schröder, M. (2008) 'Engineering eukaryotic protein factories.', Biotechnology letters., 30 (2). pp. 187-196.
The biopharmaceuticals market is currently outperforming the pharmaceuticals market and is now valued at US$ 48 billion with an average annual growth of 19%. Behind this success is a 100-fold increase in productivities of eukaryotic expression systems. However, the productivity per cell has remained unchanged for more than 10 years. The engineering of the ER-resident protein folding machinery is discussed together with an overview of signal transduction pathways activated by heterologous protein overexpression to increase cell specific productivities.
|Keywords:||Unfolded protein response, Endoplasmic reticulum, Molecular chaperone, Recombinant protein production, Heterologous protein production, Protein folding.|
|Full text:||PDF - Published Version (350Kb)|
|Publisher Web site:||http://dx.doi.org/10.1007/s10529-007-9524-1|
|Publisher statement:||This article is published under a Creative Commons Attribution (CC-BY) license.|
|Record Created:||31 May 2012 12:50|
|Last Modified:||12 Jun 2012 10:32|
|Social bookmarking:||Export: EndNote, Zotero | BibTex|
|Usage statistics||Look up in GoogleScholar | Find in a UK Library|